GHK Basic Research & Listing Availability
Current GHK Basic vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.
Current GHK Basic vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.
About GHK Basic
Cosmetic ingredientAlso known as: GHK · Glycyl-L-Histidyl-L-Lysine · GHK TripeptideGHK Basic is the unmodified glycyl-L-histidyl-L-lysine tripeptide, most often sourced for skin-repair and anti-aging research. It is the copper-free parent of GHK-Cu and **lacks the bound copper ion responsible for most published GHK-Cu effects** — see the standalone GHK-Cu entry. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.[1][2]
What to check before you buy GHK Basic:
- A third-party COA with mass-spec confirmation that the material is the copper-free GHK tripeptide — not GHK-Cu — at ≥98% purity by HPLC, since the two are routinely mislabeled and behave differently.
- A COA dated within the last 6–12 months that matches the exact vial size and batch you are buying.
- Accurate vial fill matching the label; under-filled vials are a common failure mode that skews reconstitution math.
The substantial published evidence base for "GHK" is overwhelmingly for the GHK-Cu complex rather than the bare tripeptide — see the standalone GHK-Cu entry for the wound healing, anti-fibrotic, gene-expression-modulating, hair-follicle, and skin-remodelling literature.[2] No major separate clinical program exists for unbound GHK Basic; cosmetic and research-peptide products labelled "GHK" or "GHK Basic" should be regarded as functionally similar to GHK-Cu only to the extent that they capture copper in vivo, and as substantially weaker if that copper capture is incomplete.
Regulatory: No FDA drug approval. Used as a cosmetic-ingredient peptide in topical products; the substantial clinical and pre-clinical literature is for the GHK-Cu copper complex rather than the bare tripeptide.
GHK Basic: Mechanisms, Half-Life & Research Data
A skimmable deep dive into how GHK Basic works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.
How it works
GHK Basic is the unmodified glycyl-L-histidyl-L-lysine tripeptide, the parent molecule of GHK-Cu — see the standalone GHK-Cu deep dive for the substantial published mechanism, wound-healing, anti-fibrotic, gene-expression, hair-follicle, and skin-remodelling literature that motivates most consumer use.[2][4] The mechanistically important difference is that the bare tripeptide has high binding affinity for divalent copper but does not arrive with copper already bound, while GHK-Cu is delivered as the pre-formed copper(II) complex. In copper-replete tissue, GHK Basic will opportunistically capture available copper ions and the resulting complex can recapitulate some or all of the GHK-Cu activity — but the kinetics and efficiency of in-vivo copper capture have not been characterised to the same standard as direct GHK-Cu administration, and the foundational fibroblast collagen-synthesis work specifically demonstrated that the copper complex (not the unbound tripeptide) drove the effect.[3] **The honest editorial framing is therefore: GHK Basic should be regarded as a precursor that may or may not transition to active GHK-Cu in vivo depending on local copper availability, rather than as a standalone bioactive peptide with its own independent evidence base.**
Active research areas
- Cross-reference: GHK-Cu evidence baseThe substantial published research that motivates GHK / GHK-Cu use — wound healing, anti-fibrotic, gene-expression-modulating, hair-follicle, skin remodelling — is overwhelmingly for the GHK-Cu copper complex rather than the bare tripeptide; see the standalone GHK-Cu deep dive for that evidence base in full.[2][4]
- Copper-dependence of the foundational collagen-synthesis effectMaquart 1988 specifically demonstrated that the copper complex, not the unbound tripeptide, drove the foundational fibroblast collagen-synthesis effect that motivates most cosmetic-peptide use.[3]
- No separate clinical programNo major separate clinical program exists for unbound GHK Basic;[5] cosmetic-ingredient claims for "GHK" should be assumed to depend on in-vivo copper capture to recapitulate GHK-Cu activity.
Open questions & leading hypotheses (1)
- Hypothesis: Unbound GHK Basic, applied topically or administered subcutaneously, captures available tissue copper rapidly enough to recapitulate the full GHK-Cu mechanism in skin and wound contexts.Evidence: GHK has high binding affinity for divalent copper, and skin and wound tissue contain copper that the tripeptide can opportunistically capture, providing a plausible mechanism for in-vivo conversion to GHK-Cu.[1][2] Counter-evidence: the foundational fibroblast collagen-synthesis paper specifically required the pre-formed copper complex;[3] in-vivo copper capture kinetics for unbound GHK have not been characterised to the standard of direct GHK-Cu administration; consumer products labelled "GHK" or "GHK Basic" may not deliver the full GHK-Cu activity that the published literature describes, and readers expecting GHK-Cu effects should preferentially use products labelled and delivered as the copper complex.
What community users report
Anecdotal — not controlled-trial evidence
On r/Peptides and r/SkincareAddiction, GHK and GHK-Cu are often discussed interchangeably, with users frequently unaware of the copper-binding distinction.[6] A subset of more-informed users explicitly choose GHK-Cu products over "GHK Basic" cosmetic ingredients to ensure the bound-copper form is delivered. **These reports are anecdotal, the substantial GHK published-literature claims are for the GHK-Cu complex rather than the bare tripeptide, in-vivo copper-capture kinetics for unbound GHK have not been well-characterised, no major separate clinical program for GHK Basic exists,[5] and readers expecting GHK-Cu effects should use products labelled and delivered as the copper complex.**
Sources & references (6)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol 1973;243:85–87. · PMID: 4350682 link
- [2]Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci 2018;19:1987 — comprehensive review of GHK-Cu vs. unbound GHK. · PMID: 29986520 link
- [3]Maquart FX et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988;238:343–346 — copper requirement for collagen-synthesis effects. · PMID: 3169264 link
- [4]Pickart L et al. The human tri-peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev 2012;2012:324832. · PMID: 22701753 link
- [5]ClinicalTrials.gov search "GHK tripeptide" (excluding GHK-Cu), accessed May 2026 — no major separate clinical program for unbound GHK Basic. link
- [6]Community report — r/Peptides and r/SkincareAddiction GHK vs GHK-Cu discussion threads (subreddits), accessed May 2026. link
GHK Basic Calculator Input Observations
In lifetime GHK Basic calculator inputs, 1mg is the most frequent entered amount (3 of 16 runs). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length.
About GHK Basic
GHK Basic is the unmodified glycyl-L-histidyl-L-lysine tripeptide, most often sourced for skin-repair and anti-aging research. It is the copper-free parent of GHK-Cu and **lacks the bound copper ion responsible for most published GHK-Cu effects** — see the standalone GHK-Cu entry. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.
GHK Basic is tracked under the Skin Peptides category on WPA. Its reported half-life is ~1.5 hours. Calculator inputs do not establish why a cadence was selected or validate a protocol. No FDA drug approval.
Frequently Asked Questions: GHK Basic
Are current GHK Basic offers available?
Current GHK Basic vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.
What can I check if GHK Basic listings become available?
Check the exact compound, format, labelled quantity, named laboratory, test date, and batch match. Confirm any future listing price, discount terms, and stock directly with the vendor. Catalog COA fields alone are not independent verification.
Does research activity establish current GHK Basic availability?
No. Search interest, calculator entries, historical prices, related compounds, and other formats do not establish current offers in this comparison. Research information and navigation to other compounds remain available.